Point72 Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $75.1M | Buy |
+143,108
| New | +$75.1M | 0.15% | 154 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1678 |
|
|
2024
Q3 | – | Sell |
-22,871
| Closed | -$24M | – | 1615 |
|
|
2024
Q2 | $24M | Buy |
+22,871
| New | +$24M | 0.06% | 324 |
|
|
2023
Q4 | – | Sell |
-1,407
| Closed | -$1.16M | – | 1956 |
|
|
2023
Q3 | $1.16M | Buy |
+1,407
| New | +$1.16M | ﹤0.01% | 890 |
|
|
2021
Q3 | – | Sell |
-188,700
| Closed | -$105M | – | 1138 |
|
|
2021
Q2 | $105M | Buy |
+188,700
| New | +$105M | 0.47% | 32 |
|
|
2020
Q3 | – | Sell |
-53,609
| Closed | -$33.4M | – | 1012 |
|
|
2020
Q2 | $33.4M | Buy |
+53,609
| New | +$33.4M | 0.22% | 125 |
|
|
2019
Q4 | – | Sell |
-440,940
| Closed | -$122M | – | 1149 |
|
|
2019
Q3 | $122M | Sell |
440,940
-42,905
| -9% | -$11.9M | 0.75% | 18 |
|
|
2019
Q2 | $151M | Buy |
+483,845
| New | +$151M | 0.79% | 15 |
|
|
2019
Q1 | – | Sell |
-168,644
| Closed | -$63M | – | 1074 |
|
|
2018
Q4 | $63M | Buy |
+168,644
| New | +$63M | 0.31% | 72 |
|
|
2018
Q3 | – | Sell |
-27,700
| Closed | -$9.56M | – | 1015 |
|
|
2018
Q2 | $9.56M | Sell |
27,700
-171,400
| -86% | -$59.1M | 0.04% | 356 |
|
|
2018
Q1 | $68.6M | Sell |
199,100
-282,254
| -59% | -$97.2M | 0.29% | 81 |
|
|
2017
Q4 | $181M | Buy |
+481,354
| New | +$181M | 0.78% | 11 |
|
|
2017
Q2 | – | Sell |
-70,000
| Closed | -$27.1M | – | 854 |
|
|
2017
Q1 | $27.1M | Buy |
+70,000
| New | +$27.1M | 0.15% | 169 |
|
|
2016
Q2 | – | Sell |
-109,700
| Closed | -$39.5M | – | 774 |
|
|
2016
Q1 | $39.5M | Buy |
+109,700
| New | +$39.5M | 0.3% | 77 |
|
|
2014
Q4 | – | Sell |
-23,600
| Closed | -$8.51M | – | 731 |
|
|
2014
Q3 | $8.51M | Buy |
23,600
+9,100
| +63% | +$3.28M | 0.06% | 287 |
|
|
2014
Q2 | $4.1M | Buy |
+14,500
| New | +$4.1M | 0.03% | 456 |
|